Comparison of the Impact of Biphasic Insulin Aspart 30(BiAsp30), Biphasic Insulin Aspart 70 (BiAsp 70) and Insulin Aspart on Postprandial Glucose and Lipid Metabolism During Two Consecutive Meals in Type 2 Diabetics.
Phase of Trial: Phase IV
Latest Information Update: 09 Nov 2016
At a glance
- Drugs Insulin aspart (Primary) ; Insulin aspart/insulin protamine aspart (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms HUCKEPACK2
- 07 Jun 2017 Biomarkers information updated
- 22 Sep 2011 Planned end date changed from 1 Feb 2011 to 1 Mar 2011 as reported by ClinicalTrials.gov.
- 22 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.